Partnering with clients to advance life-saving oncology treatments.
With over 30 years of deep-rooted oncology expertise, we turn knowledge into action, bringing clarity and precision to even the most complex therapeutic challenges. By accelerating the journey from breakthrough science to real-world impact, we help simplify the complex, unlock value, and enhance patient care.
Join us from May 30 – June 3 in Chicago, booth 10108. Book a meeting with our team of experts to discover how we can accelerate your oncology strategy.
Oncology is our largest therapeutic area for branded and strategic work. With deep therapeutic knowledge and a data-driven approach, we help shape impactful strategies across the oncology lifecycle.
All data analysis is based on internal revenue data and industry data available from EvaluatePharma.
We combine deep scientific expertise, data-driven insights, and tailored strategies to simplify oncology and drive smarter decisions at every pivotal moment of the journey.
Expertise powered by insights. Our oncology experts combine deep scientific knowledge with advanced data, technology, and AI-driven insights to drive smarter, faster decisions and deliver meaningful impact.
Bespoke solutions. We create tailored solutions that align scientific innovation with real-world patient needs – guiding clients through the oncology lifecycle with clarity and purpose.
Simplifying the complex. We simplify even the most complex challenges by uniting medical, strategic, and engagement expertise to help deliver the right treatments to the right patients, faster.
Explore the latest oncology insights and uncover how emerging science, shifting treatment landscapes, and real-world challenges are shaping the future of cancer care.
While significant progress has been made in focusing on patient needs, our experts emphasize that much still needs to be done.
In our latest roundtable, our experts discuss the challenges and opportunities biotech firms face when it comes to...
Congresses are an excellent way to engage with oncologists, HCPs, and other key stakeholders.
Supporting a new European division to launch brands in eight markets.
Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.